Stay updated on Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial

Sign up to get notified when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Show glossary is now enabled, and new footer items have been added: Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0, while the previous items Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T23:46:26.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    No significant changes detected in the page content or layout; the study details, eligibility criteria, and listed locations appear unchanged.
    Difference
    0.1%
    Check dated 2026-01-21T00:43:15.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed, replacing Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T02:06:30.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Page updates show minor UI and text changes with no impact on core study details (interventions, eligibility criteria, outcomes, enrollment, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-30T16:35:54.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    New sites have been added across the US, Canada, Belgium, France, Germany, Italy, the Netherlands, Poland, and the United Kingdom, and several locations were removed. The update changes where potential participants can enroll in the study.
    Difference
    2%
    Check dated 2025-12-23T10:13:32.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    No significant content changes were observed; updates are administrative and do not alter study design, eligibility, or interventions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-16T03:08:02.000Z thumbnail image

Stay in the know with updates to Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.